# SKAN AG

Source: https://en.bioecon.ru/companies/skan-ag/
Updated: 2026-08-12

- Country: Switzerland

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Acquisitions funded through a new revolving credit facility (RCF) | https://ir.skan.com/media/document/613a0a0c-b98e-4b25-a98e-154e791eea4c/assets/SKAN_Annual-Results_FINAL_24032026_a.pdf?disposition=inline |
| Production site | Allschwil (Switzerland), Görlitz (Germany), Gembloux (Belgium), Stein (Switzerland) | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://ir.skan.com/media/document/3e14993d-0e1a-4879-ad34-b3751aba0e9d/assets/SKAN_Half_Year_Report_2025.pdf?disposition=inline, https://ir.skan.com/media/document/613a0a0c-b98e-4b25-a98e-154e791eea4c/assets/SKAN_Annual-Results_FINAL_24032026_a.pdf?disposition=inline |
| Certification | ISO 9001:2015, Great Place to Work certification | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://skan.com/en/company/about |
| Headcount | 1,694 (as of June 30, 2026); 1,700 (as of February 2026) | https://skan.com/en/company/about, https://www.eqs-news.com/media/document/ae637cac-1e52-4103-89de-e75be1b88c9a/assets/SKAN_Half_Year_Report_2026.pdf |
| Revenue | CHF 333.3 million (2025 financial year) | https://stockanalysis.com/quote/swx/SKAN/, https://www.eqs-news.com/news/ad-hoc/skan-mit-gutem-auftragseingang-im-geschaeftsjahr-2025/854d5628-aa02-4d63-8c43-e0fd9c8fd428, https://www.ir.skan.com/en/news/skan-with-good-order-intake-in-the-2025-financial-year/854d5628-aa02-4d63-8c43-e0fd9c8fd428 |
| Regulatory approval | Solutions comply with EU-GMP Annex 1, FDA, and ISO standards; individual drug products filled in AT-Closed Vials have received 17-19 approvals from major authorities | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://skan.com/en/company/about, https://www.eqs-news.com/media/document/ae637cac-1e52-4103-89de-e75be1b88c9a/assets/SKAN_Half_Year_Report_2026.pdf |

Independent sources: eqs-news.com, ir-api.eqs.com, ir.skan.com, stockanalysis.com

## Technologies

- [Aseptic isolators for pharma manufacturing](https://en.bioecon.ru/technology/aseptic-isolators-pharma/)